ArticleFrontiers in oncology2024

Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors.

Ah Reum Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.